Table 2 Distribution of AL scores and AL score category in all cohort and breast cancer cases
From: Association between allostatic load and breast cancer risk: a cohort study
|  | All cohort (N = 181,455) | Case (N = 5,701) | P value |
|---|---|---|---|
AL score |  |  |  < 0.01 |
 0 | 14,046 (7.74%) | 376 (6.60%) |  |
 1 | 42,882 (23.63%) | 1,243 (21.80%) |  |
 2 | 38,012 (20.95%) | 1,143 (20.05%) |  |
 3 | 33,111 (18.28%) | 1,091 (19.14%) |  |
 4 | 24,868 (13.70%) | 871 (15.28%) |  |
 5 | 16,214 (8.94%) | 541 (9.49%) |  |
 6 | 8,313 (4.58%) | 278 (4.88%) |  |
 7 | 3,139 (1.73%) | 129 (2.26%) |  |
 8 | 741 (0.41%) | 24 (0.42%) |  |
 9 | 121 (0.07%) | 4 (0.07%) |  |
 10 | 8 (< 0.01%) | 1 (0.02%) |  |
 11 | 0 | 0 |  |
AL, continuous (mean/SD) | 2.63 (1.74) | 2.77 (1.76) |  < 0.01 |
AL category 1 |  |  |  < 0.01 |
 0 | 14,046 (7.74%) | 376 (6.60%) |  |
 1 | 42,882 (23.63%) | 1,243 (21.80%) |  |
 2 | 38,012 (20.95%) | 1,143 (20.05%) |  |
 3 | 33,111 (18.28%) | 1,091 (19.14%) |  |
 4 | 24,868 (13.70%) | 871 (15.28%) |  |
 5 | 16,214 (8.94%) | 541 (9.49%) |  |
 6 and over | 12,322 (6.79%) | 436 (7.65%) |  |
AL category 2 |  |  |  < 0.01 |
 Low (0 ~ 2) | 94,940 (52.32%) | 2,762 (48.45%) |  |
 High (3 ~ 11) | 86,515 (47.68%) | 2,939 (51.55%) |  |